Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 6 studies | 25% ± 9% | |
endothelial cell | 5 studies | 21% ± 3% | |
astrocyte | 4 studies | 22% ± 5% | |
oligodendrocyte | 4 studies | 19% ± 1% | |
GABAergic neuron | 3 studies | 38% ± 4% | |
glutamatergic neuron | 3 studies | 47% ± 5% | |
macrophage | 3 studies | 18% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1060.86 | 1445 / 1445 | 100% | 9.47 | 183 / 183 |
ovary | 100% | 1469.48 | 180 / 180 | 100% | 9.27 | 430 / 430 |
brain | 100% | 1639.29 | 2641 / 2642 | 100% | 16.31 | 705 / 705 |
breast | 100% | 1289.74 | 459 / 459 | 100% | 13.14 | 1116 / 1118 |
lung | 100% | 1263.46 | 576 / 578 | 100% | 9.69 | 1155 / 1155 |
prostate | 100% | 1280.17 | 245 / 245 | 100% | 13.37 | 500 / 502 |
thymus | 100% | 1857.21 | 653 / 653 | 100% | 14.24 | 602 / 605 |
uterus | 100% | 1387.42 | 170 / 170 | 99% | 8.17 | 456 / 459 |
stomach | 100% | 1012.96 | 359 / 359 | 99% | 9.21 | 284 / 286 |
intestine | 100% | 1310.00 | 966 / 966 | 99% | 10.15 | 523 / 527 |
bladder | 100% | 1112.52 | 21 / 21 | 99% | 8.44 | 500 / 504 |
kidney | 100% | 1277.40 | 89 / 89 | 99% | 10.97 | 891 / 901 |
pancreas | 100% | 778.84 | 328 / 328 | 99% | 7.53 | 176 / 178 |
adrenal gland | 100% | 1340.74 | 258 / 258 | 98% | 9.50 | 226 / 230 |
skin | 100% | 901.85 | 1805 / 1809 | 96% | 11.00 | 455 / 472 |
liver | 100% | 791.87 | 226 / 226 | 89% | 4.26 | 361 / 406 |
adipose | 100% | 1170.75 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1175.79 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 8.22 | 29 / 29 |
spleen | 100% | 1687.39 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 7.56 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.18 | 1 / 1 |
muscle | 100% | 1378.90 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 1161.69 | 847 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 982.34 | 867 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 84% | 4.97 | 67 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0072344 | Biological process | rescue of stalled ribosome |
GO_0070987 | Biological process | error-free translesion synthesis |
GO_0031398 | Biological process | positive regulation of protein ubiquitination |
GO_0000151 | Cellular component | ubiquitin ligase complex |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005634 | Cellular component | nucleus |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0002039 | Molecular function | p53 binding |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | RCHY1 |
Protein name | RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING finger protein 199) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363) (p53-induced RING-H2 protein) (hPirh2) RCHY1 protein PIRH2F Ring finger and CHY zinc finger domain containing 1 PIRH2E |
Synonyms | RNF199 ARNIP CHIMP ZNF363 PIRH2 |
Description | FUNCTION: E3 ubiquitin-protein ligase that mediates ubiquitination of target proteins, including p53/TP53, TP73, HDAC1 and CDKN1B . Mediates ubiquitination and degradation of p53/TP53; preferentially acts on tetrameric p53/TP53 . Catalyzes monoubiquitinates the translesion DNA polymerase POLH . Involved in the ribosome-associated quality control (RQC) pathway, which mediates the extraction of incompletely synthesized nascent chains from stalled ribosomes: RCHY1 acts downstream of NEMF and recognizes CAT tails associated with stalled nascent chains, leading to their ubiquitination and degradation . .; FUNCTION: [Isoform 4]: Has no E3 ubiquitin-protein ligase activity. . |
Accessions | ENST00000512706.5 [Q96PM5-6] G3FDP5 ENST00000513909.5 Q96BL1 ENST00000380840.6 [Q96PM5-7] ENST00000324439.10 [Q96PM5-1] G3FDP4 ENST00000507014.1 [Q96PM5-8] Q96PM5 ENST00000504085.5 D6RAF6 ENST00000505105.5 [Q96PM5-4] H0YAI4 ENST00000513257.5 [Q96PM5-2] |